The Influence of the BAD Apoptosis Pathway on Breast Cancer Progression and Relapse-Free Survival after Adjuvant Treatment

被引：0
|
作者：
Ismail-Khan, R. R.
Marichion, D. C.
Xiong, Y.
Fulp, W. J.
Kamath, S. G.
Eschrich, S. A.
Chen, D-T
Lancaster, J. M.
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P3-08-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-01
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical and pathological factors related to brain relapse-free survival in breast cancer patients
    Altundag, Kadri
    HUMAN PATHOLOGY, 2017, 69 : 141 - 142
  • [22] SIGNIFICANCE OF GENE AMPLIFICATIONS ON RELAPSE-FREE SURVIVAL (RFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER
    Todorovic-Rakovic, Natasa
    Neskovic-Konstantinovic, Zora
    Nikolic-Vukosavljevic, Dragica
    BREAST, 2013, 22 : S59 - S60
  • [23] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xionan
    Lin, Juan
    Condeelis, John S.
    Sparanno, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    CANCER RESEARCH, 2018, 78 (04)
  • [24] Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy
    Li, JunJie
    Chen, Sheng
    Chen, CanMing
    Di, GenHong
    Liu, GuangYu
    Wu, Jiong
    Shao, ZhiMin
    ONCOTARGET, 2017, 8 (11) : 18399 - 18408
  • [25] Capecitabine after surgery significantly increases relapse-free survival
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (08): : 1077 - 1078
  • [26] Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial
    Stearns, Vered
    Chapman, Judith-Anne W.
    Ma, Cynthia X.
    Ellis, Matthew J.
    Ingle, James N.
    Pritchard, Kathleen I.
    Budd, G. Thomas
    Rabaglio, Manuela
    Sledge, George W.
    Le Maitre, Aurelie
    Kundapur, Jessica
    Liedke, Pedro E. R.
    Shepherd, Lois E.
    Goss, Paul E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 265 - U163
  • [27] Prolonged tamoxifen treatment increases relapse-free survival for patients with primary breast cancer expressing high levels of VEGF
    Sanchez, B. C.
    Sundqvist, M.
    Fohlin, H.
    Spyratos, F.
    Nordenskjold, B.
    Stal, O.
    Linderholm, B. K.
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (09) : 1580 - 1587
  • [28] A competing risks cure frailty model: An application to relapse-free survival of breast cancer patients
    Ghavami, Vahid
    Mahmoudi, Mahmood
    Foroushani, Abbas Rahimi
    Baghishani, Hossein
    Yaseri, Mehdi
    Shandiz, Fatemeh Homaei
    PAKISTAN JOURNAL OF STATISTICS AND OPERATION RESEARCH, 2021, 17 (03) : 591 - 605
  • [29] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Hou, Ming-Feng
    Chen, Po-Ming
    Chu, Pei-Yi
    BMC CANCER, 2018, 18
  • [30] A Prognostic Immunoscore for Relapse-Free Survival Prediction in Colorectal Cancer
    Wang, Haizhou
    Xu, Fei
    Zhang, Meng
    Liu, Jing
    Wang, Fan
    Zhao, Qiu
    DNA AND CELL BIOLOGY, 2020, 39 (07) : 1181 - 1193
12345